Loading…
Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region
Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combin...
Saved in:
Published in: | Metabolic brain disease 2020-08, Vol.35 (6), p.991-997 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3 |
container_end_page | 997 |
container_issue | 6 |
container_start_page | 991 |
container_title | Metabolic brain disease |
container_volume | 35 |
creator | Rasouli, Babak Ghahari, Laya Safari, Manouchehr Shahroozian, Ebrahim Naeimi, Saeideh |
description | Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone. |
doi_str_mv | 10.1007/s11011-020-00579-2 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2407315459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2422472747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EotPCC7BAltiwCVz_xQm7agQUqRIbWEeOY2dcOXawHaR5pz4knk4BiQUrW_K5537Wh9ArAu8IgHyfCQFCGqDQAAjZN_QJ2hEhWSNZK56iHXSdaCTv4QJd5nwHAEyQ_jm6YJSLjrF2h-73cRldUMXFgMvBJLUecbSnK56TCpuP-lgM1tHHcMS5uGXzlQ4ztkqXmLAKE3ahJPXThLhl7N3qJmwqlk_ONcVidHkQHty6Rq2WtWLKFpPw7OOoPHZZH8ziVBXhpMoHbKPe8mlJNeyvCU5mrrIX6JlVPpuXj-cV-v7p47f9TXP79fOX_fVto5kUpbGa025iYIUegRLOOFHjOLZMtpNSmtFJtWC17rQhoHtKFO1Bd4RTPVJmJ3aF3p69NfyPzeQyLDWh8V4FU784UA6SEcFFX9E3_6B3cUuhpqsUpVxSyWWl6JnSKeacjB3W5BaVjgOB4dTlcO5yqF0OD10OtA69flRv42KmPyO_y6sAOwO5PoXZpL-7_6P9BeT-rbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2422472747</pqid></control><display><type>article</type><title>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</title><source>Springer Nature</source><creator>Rasouli, Babak ; Ghahari, Laya ; Safari, Manouchehr ; Shahroozian, Ebrahim ; Naeimi, Saeideh</creator><creatorcontrib>Rasouli, Babak ; Ghahari, Laya ; Safari, Manouchehr ; Shahroozian, Ebrahim ; Naeimi, Saeideh</creatorcontrib><description>Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.</description><identifier>ISSN: 0885-7490</identifier><identifier>EISSN: 1573-7365</identifier><identifier>DOI: 10.1007/s11011-020-00579-2</identifier><identifier>PMID: 32458336</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Apoptosis ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Brain damage ; Brain injury ; Cerebral blood flow ; Cerebrospinal fluid ; Colonies ; Colony-stimulating factor ; Combination therapy ; Free radicals ; Granulocyte colony-stimulating factor ; Granulocytes ; Hippocampus ; Injection ; Intravenous administration ; Ischemia ; Learning ; Leukocytes (granulocytic) ; Lipids ; Metabolic Diseases ; Necrosis ; Neurology ; Neurons ; Neuroprotection ; Neuroprotective agents ; Neurosciences ; Occlusion ; Oncology ; Original Article ; Regeneration ; Therapy</subject><ispartof>Metabolic brain disease, 2020-08, Vol.35 (6), p.991-997</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</citedby><cites>FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</cites><orcidid>0000-0003-3946-8965</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32458336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasouli, Babak</creatorcontrib><creatorcontrib>Ghahari, Laya</creatorcontrib><creatorcontrib>Safari, Manouchehr</creatorcontrib><creatorcontrib>Shahroozian, Ebrahim</creatorcontrib><creatorcontrib>Naeimi, Saeideh</creatorcontrib><title>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</title><title>Metabolic brain disease</title><addtitle>Metab Brain Dis</addtitle><addtitle>Metab Brain Dis</addtitle><description>Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.</description><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain damage</subject><subject>Brain injury</subject><subject>Cerebral blood flow</subject><subject>Cerebrospinal fluid</subject><subject>Colonies</subject><subject>Colony-stimulating factor</subject><subject>Combination therapy</subject><subject>Free radicals</subject><subject>Granulocyte colony-stimulating factor</subject><subject>Granulocytes</subject><subject>Hippocampus</subject><subject>Injection</subject><subject>Intravenous administration</subject><subject>Ischemia</subject><subject>Learning</subject><subject>Leukocytes (granulocytic)</subject><subject>Lipids</subject><subject>Metabolic Diseases</subject><subject>Necrosis</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neuroprotection</subject><subject>Neuroprotective agents</subject><subject>Neurosciences</subject><subject>Occlusion</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Regeneration</subject><subject>Therapy</subject><issn>0885-7490</issn><issn>1573-7365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAURi0EotPCC7BAltiwCVz_xQm7agQUqRIbWEeOY2dcOXawHaR5pz4knk4BiQUrW_K5537Wh9ArAu8IgHyfCQFCGqDQAAjZN_QJ2hEhWSNZK56iHXSdaCTv4QJd5nwHAEyQ_jm6YJSLjrF2h-73cRldUMXFgMvBJLUecbSnK56TCpuP-lgM1tHHcMS5uGXzlQ4ztkqXmLAKE3ahJPXThLhl7N3qJmwqlk_ONcVidHkQHty6Rq2WtWLKFpPw7OOoPHZZH8ziVBXhpMoHbKPe8mlJNeyvCU5mrrIX6JlVPpuXj-cV-v7p47f9TXP79fOX_fVto5kUpbGa025iYIUegRLOOFHjOLZMtpNSmtFJtWC17rQhoHtKFO1Bd4RTPVJmJ3aF3p69NfyPzeQyLDWh8V4FU784UA6SEcFFX9E3_6B3cUuhpqsUpVxSyWWl6JnSKeacjB3W5BaVjgOB4dTlcO5yqF0OD10OtA69flRv42KmPyO_y6sAOwO5PoXZpL-7_6P9BeT-rbg</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Rasouli, Babak</creator><creator>Ghahari, Laya</creator><creator>Safari, Manouchehr</creator><creator>Shahroozian, Ebrahim</creator><creator>Naeimi, Saeideh</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3946-8965</orcidid></search><sort><creationdate>20200801</creationdate><title>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</title><author>Rasouli, Babak ; Ghahari, Laya ; Safari, Manouchehr ; Shahroozian, Ebrahim ; Naeimi, Saeideh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain damage</topic><topic>Brain injury</topic><topic>Cerebral blood flow</topic><topic>Cerebrospinal fluid</topic><topic>Colonies</topic><topic>Colony-stimulating factor</topic><topic>Combination therapy</topic><topic>Free radicals</topic><topic>Granulocyte colony-stimulating factor</topic><topic>Granulocytes</topic><topic>Hippocampus</topic><topic>Injection</topic><topic>Intravenous administration</topic><topic>Ischemia</topic><topic>Learning</topic><topic>Leukocytes (granulocytic)</topic><topic>Lipids</topic><topic>Metabolic Diseases</topic><topic>Necrosis</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neuroprotection</topic><topic>Neuroprotective agents</topic><topic>Neurosciences</topic><topic>Occlusion</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Regeneration</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasouli, Babak</creatorcontrib><creatorcontrib>Ghahari, Laya</creatorcontrib><creatorcontrib>Safari, Manouchehr</creatorcontrib><creatorcontrib>Shahroozian, Ebrahim</creatorcontrib><creatorcontrib>Naeimi, Saeideh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolic brain disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasouli, Babak</au><au>Ghahari, Laya</au><au>Safari, Manouchehr</au><au>Shahroozian, Ebrahim</au><au>Naeimi, Saeideh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</atitle><jtitle>Metabolic brain disease</jtitle><stitle>Metab Brain Dis</stitle><addtitle>Metab Brain Dis</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>35</volume><issue>6</issue><spage>991</spage><epage>997</epage><pages>991-997</pages><issn>0885-7490</issn><eissn>1573-7365</eissn><abstract>Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32458336</pmid><doi>10.1007/s11011-020-00579-2</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3946-8965</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-7490 |
ispartof | Metabolic brain disease, 2020-08, Vol.35 (6), p.991-997 |
issn | 0885-7490 1573-7365 |
language | eng |
recordid | cdi_proquest_miscellaneous_2407315459 |
source | Springer Nature |
subjects | Apoptosis Biochemistry Biomedical and Life Sciences Biomedicine Brain damage Brain injury Cerebral blood flow Cerebrospinal fluid Colonies Colony-stimulating factor Combination therapy Free radicals Granulocyte colony-stimulating factor Granulocytes Hippocampus Injection Intravenous administration Ischemia Learning Leukocytes (granulocytic) Lipids Metabolic Diseases Necrosis Neurology Neurons Neuroprotection Neuroprotective agents Neurosciences Occlusion Oncology Original Article Regeneration Therapy |
title | Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A19%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20therapy%20of%20the%20granulocyte%20colony%20stimulating%20factor%20and%20intravenous%20lipid%20emulsion%20protect%20the%20hippocampus%20after%20global%20ischemia%20in%20rat:%20focusing%20on%20CA1%20region&rft.jtitle=Metabolic%20brain%20disease&rft.au=Rasouli,%20Babak&rft.date=2020-08-01&rft.volume=35&rft.issue=6&rft.spage=991&rft.epage=997&rft.pages=991-997&rft.issn=0885-7490&rft.eissn=1573-7365&rft_id=info:doi/10.1007/s11011-020-00579-2&rft_dat=%3Cproquest_cross%3E2422472747%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2422472747&rft_id=info:pmid/32458336&rfr_iscdi=true |